Inside the Tactical Tug of War Over the Controversial Alzheimer’s Drug

An epic battle is playing out behind the scenes over whether the government should pay for Aduhelm, an FDA-approved Alzheimer’s drug that scientists say has not been proven to work.
http://dlvr.it/SK4GzV

Comments

Popular posts from this blog

Bustos on Bloomberg TV: In Last Two Weeks, “Price of Gas Has Gone Down Forty Cents”

Bustos Announces More Than $7.1 Million in Federal Funding for Peoria Head Start